Exact Mass: 481.33042480000006
Exact Mass Matches: 481.33042480000006
Found 305 metabolites which its exact mass value is equals to given mass value 481.33042480000006,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
LysoPE(18:0/0:0)
LysoPE(18:0/0:0) or LPE(18:0/0:0) is a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(18:0/0:0) or LPE(18:0/0:0) is a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
1-O-Hexadecyl-sn-glycero-3-phosphocholine
C24H52NO6P (481.35320620000005)
LysoPE(0:0/18:0)
LysoPE(0:0/18:0) or LPE(0:0/18:0) is a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
LysoPC(15:0/0:0)
LysoPC(15:0) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(15:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position. The pentadecanoic acid moiety is derived from dairy products and milk fat. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins. [HMDB] LysoPC(15:0) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(15:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position. The pentadecanoic acid moiety is derived from dairy products and milk fat. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins.
N-Nervonoyl Aspartic acid
C28H51NO5 (481.37670360000004)
N-nervonoyl aspartic acid, also known as N-nervonoyl aspartate belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Nervonic acid amide of Aspartic acid. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Nervonoyl Aspartic acid is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Nervonoyl Aspartic acid is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
dihydrocytochalasin B
Palmitoyl Ara-C
C25H43N3O6 (481.31516980000004)
Phosphatidylcholine lyso alkyl 16:0
C24H52NO6P (481.35320620000005)
2-[3alpha-Hydroxy-5beta-cholen-(8(14))-oyl-(24)-amino]-aethansulfonsaeure-(1)|2-[3alpha-hydroxy-5beta-cholen-(8(14))-oyl-(24)-amino]-ethanesulfonic acid-(1)|N-[3alpha-[Hydroxy-5beta-cholen-(8(14))-oyl-(24)]-taurin
C26H43NO5S (481.2861788000001)
cyclo (-Gly-L-Orn-L-Val-3-amino-10-methyldodecanoyl-)|rhodopeptin C1
1-pentadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine
CONFIDENCE standard compound; INTERNAL_ID 259
(2-aminoethoxy)[2-hydroxy-3-(octadecanoyloxy)propoxy]phosphinic acid
His Lys Val Val
His Val Lys Val
His Val Val Lys
Ile Pro Pro Arg
Ile Pro Arg Pro
Ile Arg Pro Pro
Lys His Val Val
Lys Val His Val
Lys Val Val His
Leu Pro Pro Arg
Leu Pro Arg Pro
Leu Arg Pro Pro
Pro Ile Pro Arg
Pro Ile Arg Pro
Pro Leu Pro Arg
Pro Leu Arg Pro
Pro Pro Ile Arg
Pro Pro Leu Arg
Pro Pro Arg Ile
Pro Pro Arg Leu
Pro Arg Ile Pro
Pro Arg Leu Pro
Pro Arg Pro Ile
Pro Arg Pro Leu
Arg Ile Pro Pro
Arg Leu Pro Pro
Arg Pro Ile Pro
Arg Pro Leu Pro
Arg Pro Pro Ile
Arg Pro Pro Leu
Val His Lys Val
Val His Val Lys
Val Lys His Val
Val Lys Val His
Val Val His Lys
Val Val Lys His
PC(6:0/8:0)
C22H44NO8P (481.28043940000003)
PC(6:0/8:0)[U]
C22H44NO8P (481.28043940000003)
D-Diheptanoyllecithin
C22H44NO8P (481.28043940000003)
PC(7:0/7:0)[U]
C22H44NO8P (481.28043940000003)
PC(8:0/6:0)
C22H44NO8P (481.28043940000003)
PC(8:0/6:0)[U]
C22H44NO8P (481.28043940000003)
PC(9:0/5:0)
C22H44NO8P (481.28043940000003)
PC(O-15:0/O-1:0)[U]
C24H52NO6P (481.35320620000005)
PC(O-8:0/O-8:0)
C24H52NO6P (481.35320620000005)
PC(O-8:0/O-8:0)[U]
C24H52NO6P (481.35320620000005)
PC(15:0/0:0)
PC(15:0/0:0)[S]
PC(15:0/0:0)[U]
PC(O-16:0/0:0)[S]
C24H52NO6P (481.35320620000005)
18:0 LYSO-PE
HEPC
C23H48NO5PS (481.29906480000005)
PC(14:0/O-1:0)
PC(7:0/O-8:0)
1-[4-( Triisopropylsilyl)oxylp henyl]- 2-(4-hydroxy-4-pheny1piperidino)-1-propanone
Olumacostat glasaretil
C26H43NO7 (481.30393680000003)
C78284 - Agent Affecting Integumentary System Olumacostat glasaretil (DRM01) is a small molecule inhibitor of acetyl coenzyme A carboxylase (ACC).
2,6-bis[1-(2,6-di-i-propylphenylimino)ethyl]pyridine
Dihydrocytochalasin B
D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins
1-Hexadecyl-2-acetyl-sn-glycero-3-phosphoethanolamine
A 2-acyl-1-alkyl-sn-glycero-3-phosphoethanolamine in which the alkyl and the acyl groups at positions 1 and 2 are specified as hexadecyl and acetyl respectively.
2-(Acetyloxy)-3-(hexadecyloxy)propyl 2-aminoethyl hydrogen phosphate
(2-Hexadecoxy-3-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C24H52NO6P (481.35320620000005)
(2-Hydroxy-3-pentadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
1-stearoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine
2-azaniumylethyl (2R)-3-hydroxy-2-(octadecanoyloxy)propyl phosphate
2-Hexadecanoylthio-1-ethylphosphorylcholine
C23H48NO5PS (481.29906480000005)
2-Hexadecyl-sn-glycero-3-phosphocholine
C24H52NO6P (481.35320620000005)
(24S)-hydroxycholesterol 3-sulfate(1-)
C27H45O5S- (481.29875400000003)
(24S)-hydroxycholesterol 24-sulfate(1-)
C27H45O5S- (481.29875400000003)
1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphoethanolamine
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(phenylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-phenylethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
3-(dimethylamino)-N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylpropanamide
3-(dimethylamino)-N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylpropanamide
3-(dimethylamino)-N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylpropanamide
3-(dimethylamino)-N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylpropanamide
3-(dimethylamino)-N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylpropanamide
3-(dimethylamino)-N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylpropanamide
(2R,3S)-2-[[cyclopentylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-8-(3-methoxyphenyl)-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3R)-2-[[cyclopentylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-8-(3-methoxyphenyl)-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(4-oxanylmethyl)amino]methyl]-8-(2-methylphenyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-phenylethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(phenylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
3-(dimethylamino)-N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylpropanamide
(2R,3R)-2-[[cyclopentylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-8-(3-methoxyphenyl)-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3S)-2-[[cyclopentylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-8-(3-methoxyphenyl)-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3S)-2-[[cyclopentylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-8-(3-methoxyphenyl)-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(4-oxanylmethyl)amino]methyl]-8-(2-methylphenyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(4-oxanylmethyl)amino]methyl]-8-(2-methylphenyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(4-oxanylmethyl)amino]methyl]-8-(2-methylphenyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-phenylethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-phenylethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-phenylethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-phenylethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(phenylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(phenylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(phenylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(phenylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(phenylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
[(1S)-2-(cyclohexylmethyl)-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-(4-oxanyl)methanone
[(2R)-2-methoxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[(2R)-2,3-Dioctoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C24H52NO6P (481.35320620000005)
[(2R)-3-heptanoyloxy-2-octoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] nonanoate
C22H44NO8P (481.28043940000003)
2-Aminoethyl (2-hydroxy-3-nonadecoxypropyl) hydrogen phosphate
C24H52NO6P (481.35320620000005)
(2-Heptanoyloxy-3-octoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonoxypropan-2-yl] nonanoate
(2-Hexanoyloxy-3-nonoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octoxypropan-2-yl] decanoate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecoxypropan-2-yl] pentanoate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] heptanoate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecoxypropan-2-yl] hexanoate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-decoxypropan-2-yl] octanoate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecoxypropan-2-yl] propanoate
(2-Butanoyloxy-3-undecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
(2-Acetyloxy-3-tridecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
(3-Dodecoxy-2-propanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
(3-Decoxy-2-pentanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
(E)-2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxydec-4-ene-1-sulfonic acid
C26H43NO5S (481.2861788000001)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecoxypropan-2-yl] butanoate
N-Acetyl-O-trimethylsilylsphingatriene
C26H51NO3Si2 (481.34072960000003)
(3-Hexanoyloxy-2-octanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C22H44NO8P (481.28043940000003)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] tridecanoate
C22H44NO8P (481.28043940000003)
(3-Propanoyloxy-2-undecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C22H44NO8P (481.28043940000003)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] tetradecanoate
C22H44NO8P (481.28043940000003)
(3-Butanoyloxy-2-decanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C22H44NO8P (481.28043940000003)
(2-Nonanoyloxy-3-pentanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C22H44NO8P (481.28043940000003)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] decanoate
C22H44NO8P (481.28043940000003)
[1-Acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] pentadecanoate
C22H44NO8P (481.28043940000003)
(3-Acetyloxy-2-dodecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C22H44NO8P (481.28043940000003)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] undecanoate
C22H44NO8P (481.28043940000003)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] dodecanoate
C22H44NO8P (481.28043940000003)
2-[[2-(Decanoylamino)-3-hydroxyoctoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C23H50N2O6P+ (481.34063100000003)
2-[[2-(Butanoylamino)-3-hydroxytetradecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C23H50N2O6P+ (481.34063100000003)
2-[Hydroxy-[3-hydroxy-2-(nonanoylamino)nonoxy]phosphoryl]oxyethyl-trimethylazanium
C23H50N2O6P+ (481.34063100000003)
2-[[2-(Heptanoylamino)-3-hydroxyundecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C23H50N2O6P+ (481.34063100000003)
2-[[2-(Hexanoylamino)-3-hydroxydodecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C23H50N2O6P+ (481.34063100000003)
2-[(2-Acetamido-3-hydroxyhexadecoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
C23H50N2O6P+ (481.34063100000003)
2-[Hydroxy-[3-hydroxy-2-(propanoylamino)pentadecoxy]phosphoryl]oxyethyl-trimethylazanium
C23H50N2O6P+ (481.34063100000003)
2-[Hydroxy-[3-hydroxy-2-(pentanoylamino)tridecoxy]phosphoryl]oxyethyl-trimethylazanium
C23H50N2O6P+ (481.34063100000003)
2-[Hydroxy-[3-hydroxy-2-(octanoylamino)decoxy]phosphoryl]oxyethyl-trimethylazanium
C23H50N2O6P+ (481.34063100000003)
1-Stearoyl-sn-glycero-3-phosphoethanolamine
A 1-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as stearoyl.
2-octadecanoyl-sn-glycero-3-phosphoethanolamine zwitterion
A 2-acyl-sn-glycero-3-phosphoethanolamine zwitterion obtained by transfer of a proton from the phosphate to the amino group of 2-octadecanoyl-sn-glycero-3-phosphoethanolamine; major species at pH 7.3.
1-pentadecanoyl-sn-glycero-3-phosphocholine
A 1-O-acyl-sn-glycero-3-phosphocholine in which the acyl group is specified as pentadecanoyl.
1-O-Hexadecyl-lyso-sn-glycero-3-phosphocholine
C24H52NO6P (481.35320620000005)
lysophosphatidylcholine O-16:0/0:0
C24H52NO6P (481.35320620000005)
A lysophosphatidylcholine O-16:0e in which the hexadecyl group at C-1 contains 16 carbons of which none are unsaturated.
1,2-diheptanoyl-sn-glycero-3-phosphocholine
C22H44NO8P (481.28043940000003)
A phosphatidylcholine 14:0 in which both acyl groups are specified as heptanoyl.
1-hexadecyl-2-acetyl-sn-glycero-3-phosphoethanolamine zwitterion
A 2-acyl-1-alkyl-sn-glycero-3-phosphoethanolamine zwitterion in which the alkyl and the acyl groups at positions 1 and 2 are hexadecyl and acetyl respectively; major species at pH 7.3.
1-(1Z-hexadecenyl)-glycero-3-phosphoserine
C22H44NO8P (481.28043940000003)
1-nonanoyl-2-valeryl-sn-glycero-3-phosphocholine
C22H44NO8P (481.28043940000003)
1-(2-methoxy-6Z-heptadecenyl)-sn-glycero-3-phosphoethanolamine
lysophosphatidylethanolamine 18:0
A lysophosphatidylethanolamine in which the acyl group has a fully saturated C18 chain and is attached to the glycero moiety at either position 1 or 2.
lysophosphatidylcholine O-16:0
C24H52NO6P (481.35320620000005)
A glycerophosphocholine that is sn-glycero-3-phosphocholine bearing a hexadecyl group at an unspecified position. If R1 is hexadecyl and R2 is a hydrogen then the molecule is 1-hexadecyl-sn-glycero-3-phosphocholine. If R1 is a hydrogen and R2 is hexadecyl then the molecule is 2-hexadecyl-sn-glycero-3-phosphocholine.
lysophosphatidylcholine 15:0
An acyl-sn-glycero-3-phosphocholine in which the acyl group contains fifteen carbons with no double bonds and is attached to the glycero moiety at either position 1 or 2.
1-stearoyl-sn-glycero-3-phosphoethanolamine zwitterion
A 1-acyl-sn-glycero-3-phosphoethanolamine zwitterion obtained by transfer of a proton from the amino to the phosphate group of 1-stearoyl-sn-glycero-3-phosphoethanolamine.
2-octadecanoyl-sn-glycero-3-phosphoethanolamine
A 2-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as octadecanoyl (stearoyl).
BisMePE(16:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
MePC(13:0)
C22H44NO8P (481.28043940000003)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
MePC(14:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
LdMePE(16:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
PE(17:0)
C22H44NO8P (481.28043940000003)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
(1s,2s,3s,4r,5s,6r,8s,9s,10s,13s,16s,17r,18r)-11-ethyl-4,6,16,18-tetramethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-8,9-diol
C26H43NO7 (481.30393680000003)
(5e,7e,10e)-10-{[(1s,3ar,4s,5s,7as)-1-methyl-4-(1h-pyrrole-2-carbonyl)-2,3,3a,4,5,7a-hexahydro-1h-inden-5-yl]methylidene}-3,9-dihydroxy-8-methyldodeca-5,7-dienoic acid
(1s,2s,3r,4s,5r,6s,8r,9s,10s,13s,16r,17r,18s)-11-ethyl-4,6,16,18-tetramethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-8,9-diol
C26H43NO7 (481.30393680000003)
6-(3-aminopropyl)-3-isopropyl-13-(7-methylnonyl)-1,4,7,10-tetraazacyclotrideca-1,4,7,10-tetraene-2,5,8,11-tetrol
8-methyllycoctonine
C26H43NO7 (481.30393680000003)
{"Ingredient_id": "HBIN013832","Ingredient_name": "8-methyllycoctonine","Alias": "NA","Ingredient_formula": "C26H43NO7","Ingredient_Smile": "CCN1CC2(CCC(C34C2C(C(C31)(C5(CC(C6CC4C5C6OC)OC)OC)O)OC)OC)CO","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14562","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
aconosine; 14-benzoyl
{"Ingredient_id": "HBIN014588","Ingredient_name": "aconosine; 14-benzoyl","Alias": "NA","Ingredient_formula": "C29H39NO5","Ingredient_Smile": "NA","Ingredient_weight": "481.62","OB_score": "NA","CAS_id": "126234-20-6","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7185","PubChem_id": "NA","DrugBank_id": "NA"}
6,8,18-trimethoxy-13-(methoxymethyl)-11-propyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,9,16-triol
C26H43NO7 (481.30393680000003)
(1r,3s,4r,9s,12s,13r,14s,17s,19s,21r)-3,6,13,14,19-pentamethyl-24,27-dioxa-23-azaheptacyclo[11.10.3.1¹⁷,²¹.0¹,¹⁴.0³,¹².0⁴,⁹.0¹⁷,²³]heptacos-6-ene-8,11,25-trione
(3s,6s)-6-(3-aminopropyl)-3-isopropyl-13-(7-methylnonyl)-1,4,7,10-tetraazacyclotrideca-1,4,7,10-tetraene-2,5,8,11-tetrol
(3s,6s,13r)-6-(3-aminopropyl)-3-isopropyl-13-(7-methylnonyl)-1,4,7,10-tetraazacyclotrideca-1,4,7,10-tetraene-2,5,8,11-tetrol
(1r,2s,3s,4s,5s,6r,8s,9r,10r,13r,16s,17s,18s)-11-ethyl-4,6,16,18-tetramethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-8,9-diol
C26H43NO7 (481.30393680000003)
16-benzyl-5,13,18-trihydroxy-9,14,15-trimethyl-3h,4h,5h,6h,7h,8h,9h,10h,12ah,13h,15ah,16h-oxacyclotetradeca[2,3-d]isoindol-2-one
(1s,2r,7r,10s,11r,13r,15s)-15-methyl-7-(2-oxopropyl)-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
(1s,2r,4s,5r,6r,8r,9s,10s,13s,16s,17r,18s,20s)-11-ethyl-8,18,20-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.2⁴,⁸.0¹,¹⁰.0²,⁶.0¹³,¹⁷]icosane-5,9,16-triol
C26H43NO7 (481.30393680000003)
3-benzyl-1,12-dihydroxy-5-(hydroxymethyl)-13-methoxy-4,10,12-trimethyl-3h,3ah,4h,6ah,9h,10h,11h,13h,14h-cycloundeca[d]isoindol-15-one
(3s,3ar,4s,6s,6ar,10s,12s,13r,15as)-3-benzyl-1,6,12-trihydroxy-13-methoxy-4,10,12-trimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,11h,13h,14h-cycloundeca[d]isoindol-15-one
methyl (2s)-1-{[(3r,4s,5r)-4-hydroxy-5-methyl-2-oxo-5-pentadecyloxolan-3-yl]methyl}-5-oxopyrrolidine-2-carboxylate
6,16,18-trimethoxy-13-(methoxymethyl)-11-propyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8,9-triol
C26H43NO7 (481.30393680000003)
(1s,2r,3r,4s,5s,6s,8r,9s,10s,13s,16s,17r,18s)-11-ethyl-6,8,16,18-tetramethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,9-diol
C26H43NO7 (481.30393680000003)
(4s,5r,8r,9r)-1,8-dihydroxy-5-[(2e,4e,6e,9r)-9-hydroxy-8,10-dimethylundeca-2,4,6-trien-2-yl]-5,9-dimethyl-3-methylidene-4h,6h,7h,8h,9h-cyclohexa[e]isoindole-4-carboxylic acid
(3r,3as,4r,6ar,10r,12r,13s,15as)-3-benzyl-1,12-dihydroxy-5-(hydroxymethyl)-13-methoxy-4,10,12-trimethyl-3h,3ah,4h,6ah,9h,10h,11h,13h,14h-cycloundeca[d]isoindol-15-one
11-ethyl-6,8,16,18-tetramethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,9-diol
C26H43NO7 (481.30393680000003)
(6s,8r,9r,13s,18s)-11-ethyl-4,6,16,18-tetramethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-8,9-diol
C26H43NO7 (481.30393680000003)
2-({1-hydroxy-2-[(1-hydroxybutylidene)amino]-3-phenylpropylidene}amino)-n-(1-hydroxy-3-phenylpropan-2-yl)-3-methylpentanimidic acid
(1s,2r,4s,5r,6r,8r,9s,10s,13s,16s,17r,18s,20s)-11-ethyl-16,18,20-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.2⁴,⁸.0¹,¹⁰.0²,⁶.0¹³,¹⁷]icosane-5,8,9-triol
C26H43NO7 (481.30393680000003)
2-({1-hydroxy-2-[(1-hydroxy-3-methylbutylidene)amino]-3-phenylpropylidene}amino)-n-(1-hydroxy-3-phenylpropan-2-yl)-3-methylbutanimidic acid
(1s,2r,3r,4s,5r,6s,8r,9s,10s,13s,16r,17r,18s)-11-ethyl-4,6,16,18-tetramethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-8,9-diol
C26H43NO7 (481.30393680000003)
11-ethyl-4,6,16,18-tetramethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-8,9-diol
C26H43NO7 (481.30393680000003)
(1r,4s,5r,7r,9e,11s,12r,14s,15r,16s,17r)-17-benzyl-5,19-dihydroxy-4-methoxy-5,7,14,15-tetramethyl-13-oxa-18-azatetracyclo[9.8.0.0¹,¹⁶.0¹²,¹⁴]nonadeca-9,18-dien-2-one
(2s)-2-{[(2s)-1-hydroxy-2-[(1-hydroxy-3-methylbutylidene)amino]-3-phenylpropylidene]amino}-n-[(2s)-1-hydroxy-3-phenylpropan-2-yl]-3-methylbutanimidic acid
11-ethyl-8,18,20-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.2⁴,⁸.0¹,¹⁰.0²,⁶.0¹³,¹⁷]icosane-5,9,16-triol
C26H43NO7 (481.30393680000003)
11-ethyl-16,18,20-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.2⁴,⁸.0¹,¹⁰.0²,⁶.0¹³,¹⁷]icosane-5,8,9-triol
C26H43NO7 (481.30393680000003)
(2s,3s)-2-{[(2s)-1-hydroxy-2-[(1-hydroxybutylidene)amino]-3-phenylpropylidene]amino}-n-[(2s)-1-hydroxy-3-phenylpropan-2-yl]-3-methylpentanimidic acid
17-benzyl-5,19-dihydroxy-4-methoxy-5,7,14,15-tetramethyl-13-oxa-18-azatetracyclo[9.8.0.0¹,¹⁶.0¹²,¹⁴]nonadeca-9,18-dien-2-one
methyl 1-[(4-hydroxy-5-methyl-2-oxo-5-pentadecyloxolan-3-yl)methyl]-5-oxopyrrolidine-2-carboxylate
(3s,6s,9r)-5,8,11-trihydroxy-3,6,9-tris(2-methylpropyl)-13-pentyl-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-2-one
(2-{[(2r)-3-(hexadecyloxy)-2-hydroxypropyl phosphonato]oxy}ethyl)trimethylazanium
C24H52NO6P (481.35320620000005)
3-benzyl-1,6,12-trihydroxy-13-methoxy-4,10,12-trimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,11h,13h,14h-cycloundeca[d]isoindol-15-one
(2-{[(2r)-3-{[(2r)-2,12-dimethyltridecanoyl]oxy}-2-hydroxypropyl phosphonato]oxy}ethyl)trimethylazanium
(2s,3as,6r,9as,10ar)-7'-[(2s)-3,3-dimethyloxirane-2-carbonyl]-1,1,6-trimethyl-3a-(methylamino)-3,4,6,7,8,9,9a,10-octahydrospiro[cyclopenta[b]quinolizine-2,3'-indole]-2',10a-diol
(1s,2r,3r,4s,5r,6s,8r,9s,10s,13s,16s,17r,18s)-11-ethyl-4,6,16,18-tetramethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-8,9-diol
C26H43NO7 (481.30393680000003)